Ocella
Product Images NDC 0555-9131

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ocella (NDC 0555-9131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

26feec7e 7793 4094 899d C3b40a4f0eba 00

A forest plot chart titled 'Relevant Studies of Risk of Breast Cancer with Combined Oral Contraceptives' compares the effect estimates of various studies for 'Ever COC vs. Never COC Use' and 'Current COC use vs. Never-Use.' The chart shows confidence intervals and odds ratios, risk ratios, or hazard ratios for each study along an effect estimate axis ranging from -1.50 to 2.00.*

FDA Label Image

Figure 2 (7ae51f8c 8ea0 4502 8d7b D0c0b1a295ba 02)

A horizontal bar chart depicting the number of women with a blood clot out of 10,000 women years (WY) in different groups: Non-Pregnant Non-COC users (range 1 to 5), COC users (range 3 to 9), Pregnancy (range 5 to 20), and Postpartum (12 weeks only, range 40 to 65). The chart visually compares blood clot risks among these groups.*

FDA Label Image

Structural Formulas (7ae51f8c 8ea0 4502 8d7b D0c0b1a295ba 03)

Chemical structure diagram showing two active ingredients: Drospirenone on the left and Ethinyl estradiol on the right. Each structure is labeled with its respective ingredient name below the molecular drawing.*

FDA Label Image

Pregnancy Diagram (7ae51f8c 8ea0 4502 8d7b D0c0b1a295ba 04)

An illustration displaying a vertical effectiveness scale for various birth control methods. It ranges from fewer pregnancies per 100 women per year at the top to more pregnancies at the bottom. Methods listed from most to least effective include implants, injections, intrauterine devices, sterilization; birth control pills, skin patch, vaginal ring with hormones; condoms, diaphragm; no sex during fertile days, spermicide, withdrawal; and no birth control at the bottom.*

FDA Label Image

Ocella Foil (7ae51f8c 8ea0 4502 8d7b D0c0b1a295ba 05)

An illustrated medication blister pack for OCELLA showing a 4-week cycle of pills, labeled by week and day of the week. Weeks 1-3 contain active pills (shaded), and Week 4 contains inactive pills (unshaded). The active pills contain drospirenone and ethinyl estradiol. The pack directs starting on Monday and following the sequence through Sunday each week.*

FDA Label Image

Blood Clot Diagram (7ae51f8c 8ea0 4502 8d7b D0c0b1a295ba 06)

A bar chart depicting the number of women with a blood clot per 10,000 women years, categorized by non-pregnant non-COC users, COC users, pregnant women, and postpartum women (12 weeks only). The values range from 1 to 5 for non-pregnant non-COC users, 3 to 9 for COC users, 5 to 20 for pregnancy, and 40 to 65 for postpartum women.*

FDA Label Image

Ocella Trade Carton (7ae51f8c 8ea0 4502 8d7b D0c0b1a295ba 07)

Ocella (drospirenone and ethinyl estradiol tablets) 3 mg / 0.03 mg carton packaging. The label indicates a 3-month supply with a total of 28 tablets (3 tablets per dispenser, 3 dispensers). The labeler is Teva Pharmaceuticals USA, Inc. The packaging features the phrase 'Shaping Women's Health' and the product NDC 0555-9131.*

FDA Label Image

Fig 1 (Image 01)

A forest plot figure comparing risk ratios or odds ratios from multiple studies (Ingenix, EURAS, LASS, FDA-funded study, Danish, Danish re-analysis, MEGA study, German case-control, PharMetrics, GPRD study) grouped by study design type (prospective cohort, retrospective cohort, case-control, non-fatal idiopathic cases). The horizontal axis displays a logarithmic scale ranging from 0.1 to 10, with markers showing effect sizes and confidence intervals for each study.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.